Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Up 5.3% in January

Delcath Systems, Inc. (NASDAQ:DCTH) was the target of a large increase in short interest in January. As of January 31st, there was short interest totalling 986,900 shares, an increase of 5.3% from the January 15th total of 937,100 shares. Based on an average trading volume of 437,700 shares, the days-to-cover ratio is currently 2.3 days.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. HC Wainwright restated a “buy” rating and issued a $22.00 price target on shares of Delcath Systems in a research report on Tuesday, January 14th. StockNews.com upgraded shares of Delcath Systems from a “sell” rating to a “hold” rating in a research report on Friday, October 25th. Finally, Craig Hallum upped their price target on shares of Delcath Systems from $18.00 to $21.00 and gave the company a “buy” rating in a research report on Friday, January 17th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $22.25.

Institutional Investors Weigh In On Delcath Systems

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Soleus Capital Management L.P. acquired a new position in shares of Delcath Systems during the 4th quarter worth $9,644,000. Vivo Capital LLC increased its stake in shares of Delcath Systems by 71.4% during the 4th quarter. Vivo Capital LLC now owns 1,708,579 shares of the company’s stock worth $20,571,000 after purchasing an additional 711,574 shares during the last quarter. Gilder Gagnon Howe & Co. LLC acquired a new position in shares of Delcath Systems during the 4th quarter worth $7,371,000. Polar Asset Management Partners Inc. acquired a new position in shares of Delcath Systems during the 3rd quarter worth $1,594,000. Finally, Jane Street Group LLC increased its stake in shares of Delcath Systems by 1,364.6% during the 4th quarter. Jane Street Group LLC now owns 178,797 shares of the company’s stock worth $2,153,000 after purchasing an additional 166,589 shares during the last quarter. Hedge funds and other institutional investors own 61.12% of the company’s stock.

Delcath Systems Trading Up 0.6 %

DCTH stock opened at $16.37 on Wednesday. Delcath Systems has a 12-month low of $3.70 and a 12-month high of $16.97. The company has a 50 day moving average of $13.77 and a two-hundred day moving average of $11.13.

About Delcath Systems

Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.